Induction of a multiple sclerosis-like disease in mice with an immunodominant epitope of myelin oligodendrocyte glycoprotein

Autoimmunity

Volumn 28, Issue 2, 1998, Pages 109-120

  Slavin, Anthony ^a,c   Ewing, Christine ^a   Liu, Junliang ^a   Ichikawa, Motoki ^a,d   Slavin, John ^b   Bernard, Claude C A ^a  

^a LA TROBE UNIVERSITY   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c HARVARD MEDICAL SCHOOL   (United States)

^d SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Antibody; Delayed hypersensitivity reaction; Demyelination; Encephalitogenic peptide; Multiple sclerosis; Myelin oligodendrocyte glycoprotein

Indexed keywords

AUTOANTIGEN; ENCEPHALITOGENIC PROTEIN; EPITOPE; MYELIN; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; CELL INFILTRATION; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DEMYELINATION; FEMALE; HISTOPATHOLOGY; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PARALYSIS;

EID: 0000337323     PISSN: 08916934     EISSN: None     Source Type: Journal    
DOI: 10.3109/08916939809003872     Document Type: Article

References (35)

1. Raine, C.C., Johnson, A.B., Marcus, D.M., Suzuki, A. and Bornstein, M.B. Demyelination in vitro: Absorption studies demonstrate that galactocerebroside is a major target. J. Neurol. Sci. 1981; 52: 117-131.
2. Lassmann. H. Chronic relapsing experimental allergic encephalomyelitis: its value as an experimental model for multiple sclerosis. J. Neurol. 1983; 229: 207-220.
3. Bernard, C.C.A. and Kerlero de Rosbo, N. Multiple sclerosis: an autoimmune disease of multifactorial etiology Curr. Opin. Immunol. 1992; 4: 760-765.
4. Raine, C.S. Biology of disease. Analysis of autoimmune demyelination: its impact on multiple sclerosis. Lab. Invest. 1984; 50: 608-635.
5. Glynn, P. and Linington, C. Cellular and molecular mechanisms of autoimmune demyclination in the central nervous system. CRC Crit. Rev. Neurobiol. 1989; 4: 367-387.
6. Lebar, R., Boutry, J-M., Vincent, C., Robineaux, R. and Voisin. G.A. Studies on autoimmune encephalomyelitis in the guinea pig II. An in vitro investigation on the nature, properties and specificity of the serum demyelinating activity. J. Immunol. 1976; 116: 1439-1446.
7. Lebar, R. and Vincent, C. Studies on autoimmune encephalomyelitis in the guinea pig IV. Relative dependence of acute and chronic diseases. Immunol. Lett. 1981; 2: 239-244.
8. Lebar, R., Lubetski, C., Vincent, C., Lombrail, P. and Boutry, J -M. The M2 autoantigen of central nervous system myelin, a glycoprotein present in oligodendrocyte membrane. Clin. Exp. Immunol. 1986; 66: 423-443.
9. Linington, C., Webb, M. and Woodhams. P. A novel myelin-associatcd protein defined by a mouse monoclonal antibody. J. Neuroimmunol. 1984; 6: 387-396.
10. Gardinier, M.V., Amiguet, P., Linington, C. and Matthieu. J-M. Myelin oligodendrocyte glycoprotein is a member of the immunoglobulin superfamily. J. Neurosci. Res. 1992; 33: 177-187.
11. Kerlero de Rosbo, N., Honegger, P., Lassman, H. and Matthieu. J-M. Demyelination induced in aggregating brain cell cultures by a monoclonal antibody against myelin oligodendrocyte glycoprotein (MOG). J. Neurochem. 1990; 55: 583-587.
12. Linington, C., Bradl, M., Lassman, H., Brunner, C. and Vass, K. Augmentation of demyelination in rat acute allergic encephalomyelitis by circulating mouse monoclonal antibodies directed against a myelin/oligodendrocyte glycoprotein. Am. J. Pathol. 1988; 130: 443-454.
13. Schlucsener, H.J., Sobel, R.A., Linington, C. and Weiner, H.L. A monoclonal antibody against a myelin oligodendrocyte glycoprotein induces relapses and demyelination in central nervous system autoimmune disease. J. Immunol. 1987; 139: 4016-4021.
14. Linington, C., Engelhardt, B., Kapocs, G. and Lassman, H. Induction of persistently demyelinated lesion in the rat following the repeated adoptive transfer of encephalitogenic T-cells and demyelinating antibody. J. Neuroimmunol. 1992; 40: 219-224.
15. Piddlesden, S.J., Lassman, H., Zimprich, F., Morgan, B.P. and Linington, C . The demyelinating potential of antibodies to myelin oligodendrocyte glycoprotein is related to their ability to fix complement. Am. J. Pathol. 1993; 143: 555-564.
16. Kerlero de Rosbo, N., Milo, R., Lees, M.B., Burger, D., Bernard, C.C.A. and Ben-Nun. A. Reactivity to myelin antigens in multiple sclerosis. J. Clin. Invest. 1993; 92: 2602-2608.
17. Linington, C., Berger, T., Perry, L., Weerth, S., Hinze-Selch, D., Zhang, Y., Lu, H., Lassman, H. and Wekerle, H. T cells specific for the myelin oligodendrocyte glycoprotein mediate an unusual autoimmune inflammatory response in the central nervous system. Eur. J. Immunol. 1993; 23: 1364-1372.
18. Johns, T.G., Kerlero de Rosbo, N., Menon, K.K., Abo, S., Gonzales, M.F. and Bernard, C.C.A. Myelin oligodendrocyte glycoprotein induces a demyelinating encephalomyelitis resembling multiple sclerosis. J. Immunol. 1995; 154: 5536-5541.
19. Ichikawa, M., Johns, T.G., Liu, J. and Bernard, C.C.A. Analysis of the fine B-cell specificity during the chronic relapsing course of a multiple sclerosis-like disease in Lewis rats injected with encephalitogenic myelin oligodendrocyte glycoprotein peptide 35 55. J. Immunol. 1996; 157: 919-926.
20. Ichikawa, M., Johns, T.G., Aldelmann, M. and Bernard, C.C.A Antibody response in Lewis rais injected with myelin oligodendrocyte glycoprotein-derived peptides. Int. Immunol. 1997; 8: 1667-1674.
21. Bernard, C.C.A. Experimental antoimmune encephalomyelitis in mice: genetic control of susceptibility. J. Immunogenet. 1976; 3: 263-274.
22. Zamvil, S.S. and Steinman, L. The T-cells in experimental allergic encephalomyelitis. Ann. Rev. Immunol. 1990; 8: 579-621.
23. Bernard, C.C.A., Johns, T.G. Slavin, A., lchikawa, M., Ewing, C., Liu, J. and Bettadapura, J. Myelin oligodendrocyte glycoprotein: a novel candidate autoantigen in multiple sclerosis.J. Mol. Med. 1997; 75: 77-88.
24. Bernard, C.C.A. and Carnegie, P.R. Experimental autoimmune encephalomyelitis in mice: Immunologic response to mouse spinal cord and myelin basic proteins. J. Immunol. 1975; 114: 1537-1540.
25. Munoz, J.J., Bernard, C.C.A. and Mackay, I.R. Elicitation of experimental allergic encephalomyelitis (EAE) in mice with the aid of pertussigen. Cell. Immunol. 1984; 83: 92-100.
26. Ben-Nun, A., Mendel, I. and Kerlero de Rosbo, N. Immunomodulation of murine experimental autoimmune encephalomyelitis by pertussis toxin: the protective activity, but not the disease-enhancing activity, can be attributed to the nontoxic B-oligomer. Proc. Assoc. Amer. Physic. 1997 109: 120-125
27. 3 expression of encephalitogenic T-cells. Eur. J. Immunol. 1995; 25: 1951-1959.
28. Amor, S., Groome, N., Linington, C., Morris, M.M., Dornmair, K., Gardinier, M.V., Matthieu, J-M. and Baker, D. Identification of epitopes of myelin oligodendrocyte glycoprotein for the induction of experimental allergic encephalomyelitis in SJL and AB/H Biozzi mice. J. Immunol. 1994; 153: 4349-4356.
29. Greer, J.M., Kuchroo, V.K., Sobel, R.A. and Lees, M.B. Identification and characterization of a second encephalitogenic determinant of myelin proteolipid protein (residues 178 191) for SJL mice. J. Immunol. 1992; 149: 783-788.
30. Tahira, T. and Kira, J. Strain and species differences of encephalitogenic determinants of myelin basic protein and proteolipid apoprotein. In: Materson, R.E. ed. Myelin: Biology and Chemistry. Boca Raton, FL: CRC Press. 1992: 783-799.
31. Kerlero de Rosbo, N., Mendel, I. and Ben-Nun, A. Chronic relapsing experimental autoimmune encephalomyelitis with a delayed onset and an atypical clinical course, induced in PL/J mice by myelin oligodendrocyte glycoprotein (MOG)-derived peptide: preliminary analysis of MOG T cell epitopes. Eur. J. Immunol. 1995; 25: 985-993.
32. Tuohy, V.K. and Thomas, D.M. Sequence 104 117 of myelin proteolipid protein is a cryptic encephalitogenic T cell determinat for SJL J mice. J. Neuroimmunol. 1995; 56: 161-170.
33. Adams, C.W.M. The general pathology of multiple-sclerosis: Morphological and chemical aspects of the lesions. In: Hallpike, J.F., Adams, C.W.M., Tourtellotte, W.W. eds. Multiple Sclerosis: Pathology, diagnosis and management. London; Chapman and Hall 1983: 203-240.
34. Devaux, B., Enderlin, F., Wallner, B. and Smilek, D.E. Induction of EAE in mice recombinant human MOG, and treatment of EAE with a MOG pcptide. J. Neuroimmunol. 1997; 75: 169-173.
35. Mossmann, T.R. and Coffman, R.L. Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Ann. Rev. Immunol. 1989; 7: 143-173.